1
|
Paraskevas KI, Mukherjee D, Liapis CD, Veith FJ. Statin Use and Cardiovascular Event/Death Rates After Abdominal Aortic Aneurysm Repair Procedures. Curr Vasc Pharmacol 2022; 20:313-314. [PMID: 34602047 DOI: 10.2174/1570161119666210930100154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 09/19/2021] [Accepted: 09/21/2021] [Indexed: 01/25/2023]
Affiliation(s)
| | - Debabrata Mukherjee
- Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, 79905, U.S.A
| | | | - Frank J Veith
- Division of Vascular Surgery, New York University Langone Medical Center, New York, 10016, U.S.A.,Division of Vascular Surgery, The Cleveland Clinic, Cleveland, OH, 44106, U.S.A
| |
Collapse
|
2
|
Paraskevas KI, Eckstein HH, Veith FJ. Prevention and Treatment of Ruptured Abdominal Aortic Aneurysms. Angiology 2020; 71:586-588. [DOI: 10.1177/0003319720923808] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- Kosmas I. Paraskevas
- Department of General and Vascular Surgery, Central Clinic of Athens, Athens, Greece
| | - Hans-Henning Eckstein
- Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Frank J. Veith
- Divisions of Vascular Surgery, New York University Langone Medical Center, New York, NY, USA
- The Cleveland Clinic, Cleveland, OH, USA
| |
Collapse
|
3
|
Paraskevas KI, Brar R, Constantinou J, Tsui J, Baker DM. Screening Programs for Abdominal Aortic Aneurysms: Luxury or Necessity? Angiology 2018; 70:385-387. [DOI: 10.1177/0003319718766740] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Kosmas I. Paraskevas
- Department of Vascular and Endovascular Surgery, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
| | - Ranjeet Brar
- Department of Vascular and Endovascular Surgery, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
| | - Jason Constantinou
- Department of Vascular and Endovascular Surgery, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
| | - Janice Tsui
- Department of Vascular and Endovascular Surgery, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
| | - Daryll M. Baker
- Department of Vascular and Endovascular Surgery, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
| |
Collapse
|
4
|
Zhang W, Liu Z, Liu C. Effect of lipid-modifying therapy on long-term mortality after abdominal aortic aneurysm repair: a systemic review and meta-analysis. World J Surg 2015; 39:794-801. [PMID: 25385163 DOI: 10.1007/s00268-014-2858-7] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
BACKGROUND Several observational studies have demonstrated that lipid-modifying therapy may improve long-term survival in abdominal aortic aneurysm (AAA) patients after repair. We carried out a systematic review and meta-analysis of studies evaluating the effect of lipid-modifying therapy on long-term mortality. PATIENTS AND METHODS We conducted a systematic search of multiple databases up to April 2014. Studies that evaluated exposure to lipid-modifying therapy, reported mortality data and hazard ratio (HR) or provided survival curve for their estimation were included in the meta-analysis. Pooled HR estimates with 95% confidence intervals (CIs) were calculated using the random-effects model. RESULTS Eight studies (seven cohorts, one post hoc study of a randomization controlled trial) reporting 2,605 patients on lipid-modifying therapy were included. Meta-analysis showed a significant 39% reduction in long-term mortality with lipid-modifying therapy (HR 0.61; 95% CI 0.51-0.73). After exclusion of one study which was contributing to considerable heterogeneity, a significant 33% reduction in mortality risk was a more conservative, consistent estimate (HR 0.67; 95% CI 0.59-0.77). CONCLUSION Meta-analysis of studies supports a protective role of lipid-modifying therapy on mortality risk after AAA repair. Aggressive lipid intervention should be recommended to those who receiving AAA repair.
Collapse
Affiliation(s)
- Wenwen Zhang
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, People's Republic of China
| | | | | |
Collapse
|
5
|
Grant S, Hickey G, Wisely N, Carlson E, Hartley R, Pichel A, Atkinson D, McCollum C. Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repair †. Br J Anaesth 2015; 114:430-6. [DOI: 10.1093/bja/aeu383] [Citation(s) in RCA: 68] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
|
6
|
Statins: A sine qua non of the management of patients with abdominal aortic aneurysms. Int J Cardiol 2013; 168:4528. [DOI: 10.1016/j.ijcard.2013.06.102] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2013] [Accepted: 06/30/2013] [Indexed: 11/17/2022]
|
7
|
Abstract
BACKGROUND Screening for abdominal aortic aneurysm (AAA) in selected groups is now performed in England, the USA and Sweden. Patients with aneurysms over 55 mm in diameter are generally considered for elective surgical repair. Patients with aneurysm diameters below or equal to 55 mm (termed 'small AAAs') are managed with aneurysm surveillance as there is currently insufficient evidence to recommend surgery in these cases. As more patients are screened, there will be an increasing number of small AAAs identified. There is interest in pharmaceutical interventions (for example angiotensin converting enzyme (ACE) inhibitors, antibiotics, beta-blockers, statins) which could be given to such patients to delay or reverse aneurysm expansion and reduce the need for elective surgical repair. OBJECTIVES To assess the effects of medical treatment on the expansion rate of small abdominal aortic aneurysms. SEARCH METHODS The Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (May 2012) and CENTRAL (2012, Issue 5). Clinical trials databases were searched for details of ongoing or unpublished studies. The reference lists of articles retrieved by electronic searches were searched for additional citations. SELECTION CRITERIA We selected randomised trials in which patients with small AAAs allocated to medical treatment with the intention of retarding aneurysm expansion were compared to patients allocated to a placebo treatment, alternative medical treatment, a different regimen of the same drug or imaging surveillance alone. DATA COLLECTION AND ANALYSIS Two authors independently extracted the data and assessed the risk of bias in the trials. Meta-analyses were used when heterogeneity was considered low. The two primary outcomes were the mean difference (MD) in aneurysm diameter and the odds ratio (OR) calculated to compare the number of individuals referred to AAA surgery in each group over the trial period. MAIN RESULTS Seven trials involving 1558 participants were included in this review; 457 were involved in four trials of antibiotic medication, and 1101 were involved in three trials of beta-blocker medication. Five of the studies were rated at a high risk of bias.Individually, all of the included trials reported non-significant differences in AAA expansion rates between their intervention and control groups.The two major drug groups were then analysed separately. For AAA expansion it was only possible to combine two of the antibiotic trials in a meta-analysis. This demonstrated that roxithromycin had a small but significant protective effect (MD -0.86 mm; 95% confidence interval (CI) -1.57 to -0.14). When referral to AAA surgery was compared (including all four antibiotic trials in the meta-analysis), non-significantly fewer patients were referred in the intervention groups (OR 0.96; 95% CI 0.59 to 1.57) than the control groups. When only the trials reporting actual elective surgery were included in a subgroup analysis, the result remained statistically non-significant (OR 1.17; 95% CI 0.57 to 2.42).For the beta-blocker trials, when all were combined in a meta-analysis, there was a very small, non-significant protective effect for propranolol on AAA expansion (MD -0.08 mm; 95% CI -0.25 to 0.10), and non-significantly fewer patients were referred to AAA surgery in the propranolol group (OR 0.74; 95% CI 0.52 to 1.05). Bronchospasm and shortness of breath were the main adverse effects from the beta-blockers. In one trial the adverse effects were reportedly so severe that the trial was stopped early after two years. AUTHORS' CONCLUSIONS There is some limited evidence that antibiotic medication may have a slight protective effect in retarding the expansion rates of small AAAs. The quality of the evidence makes it unclear whether this translates into fewer referrals to AAA surgery, owing mainly to the small sample sizes of the studies.Antibiotics were generally well tolerated with minimal adverse effects. Propranolol was poorly tolerated by patients in all of the beta-blocker trials and demonstrated only minimal and non-significant protective effects. Further research on beta-blockers for AAA needs to consider the use of drugs other than propranolol.In general, there is surprisingly little high quality evidence on medical treatment for small AAAs, especially in relation to the use of newer beta-blockers, ACE inhibitors and statins.
Collapse
Affiliation(s)
- Guy Rughani
- The Medical School, The University of Edinburgh, Edinburgh, UK.
| | | | | |
Collapse
|
8
|
Antoniou GA, Georgiadis GS, Antoniou SA, Murray D, Smyth JV, Serracino-Inglott F, Paraskevas KI. Plasma Matrix Metalloproteinase 9 Levels May Predict Endoleaks After Endovascular Aortic Aneurysm Repair. Angiology 2012; 64:49-56. [DOI: 10.1177/0003319712458537] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- George A. Antoniou
- Department of Vascular and Endovascular Surgery, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| | - George S. Georgiadis
- Department of Vascular and Endovascular Surgery, Democritus University of Thrace, Alexandroupolis, Greece
| | - Stavros A. Antoniou
- Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany
| | - David Murray
- Department of Vascular and Endovascular Surgery, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| | - J. Vincent Smyth
- Department of Vascular and Endovascular Surgery, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| | - Ferdinand Serracino-Inglott
- Department of Vascular and Endovascular Surgery, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
- Cardiovascular Medicine Research Group, Research School of Clinical and Laboratory Sciences within the School of Medicine, The University of Manchester, Manchester, UK
| | - Kosmas I. Paraskevas
- Department of Vascular and Endovascular Surgery, Manchester Royal Infirmary, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
| |
Collapse
|
9
|
Antoniadis PN, Kyriakidis KD, Paraskevas KI. A simple booklet for patient follow-up after endovascular abdominal aortic aneurysm repair procedures. Angiology 2012; 63:634-7. [PMID: 22323834 DOI: 10.1177/0003319711435937] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Endovascular abdominal aortic aneurysm (AAA) repair (EVAR) procedures require lifelong patient surveillance for the detection of complications (eg, endoleaks or graft migration). This follow-up may be suboptimal. Between November 2010 and November 2011, a follow-up booklet was provided at hospital discharge to 42 consecutive patients undergoing EVAR for an infrarenal AAA. Each patient was given specific instructions for completion of the booklet at each follow-up examination whether this took place at our hospital or elsewhere. After a mean follow-up of 7 ± 3 months, all patients had fully complied with the instructions. This booklet may be useful for patients who find it difficult to attend follow-up appointments. Additionally, this booklet is useful for patients who move to another town/country or in cases of emergency when patients are admitted to another hospital.
Collapse
Affiliation(s)
- Pavlos N Antoniadis
- Department of Vascular Surgery, Konstantopouleio General Hospital, N Ionia, Athens, Greece
| | | | | |
Collapse
|
10
|
Hong H, Yang Y, Liu B, Cai W. Imaging of Abdominal Aortic Aneurysm: the present and the future. Curr Vasc Pharmacol 2011; 8:808-19. [PMID: 20180767 DOI: 10.2174/157016110793563898] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2009] [Accepted: 01/07/2010] [Indexed: 01/02/2023]
Abstract
Abdominal Aortic Aneurysm (AAA) is a common, progressive, and potentially lethal vascular disease. A major obstacle in AAA research, as well as patient care, is the lack of technology that enables non-invasive acquisition of molecular/cellular information in the developing AAA. In this review we will briefly summarize the current techniques (e.g. ultrasound, computed tomography, and magnetic resonance imaging) for anatomical imaging of AAA. We also discuss the various functional imaging techniques that have been explored for AAA imaging. In many cases, these anatomical and functional imaging techniques are not sufficient for providing surgeons/clinicians enough information about each individual AAA (e.g. rupture risk) to optimize patient management. Recently, molecular imaging techniques (e.g. optical and radionuclide-based) have been employed to visualize the molecular alterations associated with AAA, which are discussed in this review. Lastly, we try to provide a glance into the future and point out the challenges for AAA imaging. We believe that the future of AAA imaging lies in the combination of anatomical and molecular imaging techniques, which are largely complementary rather than competitive. Ultimately, with the right molecular imaging probe, clinicians will be able to monitor AAA growth and evaluate the risk of rupture accurately, so that the life-saving surgery can be provided to the right patients at the right time. Equally important, the right imaging probe will also allow scientists/clinicians to acquire critical data during AAA development and to more accurately evaluate the efficacy of potential treatments.
Collapse
Affiliation(s)
- Hao Hong
- Department of Radiology, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI 53705-2275, USA
| | | | | | | |
Collapse
|
11
|
Paraskevas KI, Mikhailidis DP, Veith FJ. Optimal statin type and dosage for vascular patients. J Vasc Surg 2011; 53:837-44. [PMID: 21215572 DOI: 10.1016/j.jvs.2010.10.114] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2010] [Revised: 10/14/2010] [Accepted: 10/23/2010] [Indexed: 12/29/2022]
Abstract
Statins are an essential component of the management of patients suffering from vascular diseases. As there is neither any consensus nor any guidelines regarding this issue, we aimed to define the optimal statin type and dosage for these patients. MEDLINE was searched for studies comparing different statin types and dosages for vascular patients. In the absence of adverse effects, rosuvastatin or atorvastatin ≥ 20 mg/d is the optimal statin type and dosage for vascular patients. The management of statin-induced adverse events and the options for statin-intolerant patients are also discussed. Routine statin treatment is associated with several beneficial effects in vascular patients whether managed conservatively or undergoing open vascular surgery/endovascular interventions. If possible, statins should not be discontinued before open or endovascular procedures and treatment should be resumed as soon as possible. Future studies should evaluate the effects of an increased statin loading dose prior to vascular procedures.
Collapse
|
12
|
Paraskevas KI, Kotsikoris I, Koupidis SA, Tzovaras AA, Mikhailidis DP. Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention. Int Urol Nephrol 2010; 42:999-1006. [DOI: 10.1007/s11255-010-9795-7] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2010] [Accepted: 06/11/2010] [Indexed: 12/14/2022]
|
13
|
Jie Li, Lu WM, Li XX, Wang SM, Yu JX, Zhu YF, Liu DY, Huang MQ. Intensive statin therapy: a favorable adjunct to the improvement of small-diameter vascular grafts. Angiology 2010; 61:427-36. [PMID: 20395233 DOI: 10.1177/0003319709356422] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
To assess the effect of intensive statins therapy on the outcome of small-diameter vascular prosthesis, we investigated whether atorvastatin treatment (30 mg/d) could accelerate the re-endothelialization process and improve the patency rate in a canine infrarenal abdominal aorta-expanded polytetrafluoroethylene (ePTFE) bypass model. Furthermore, we also evaluated the effect of atorvastatin on the migratory and adherent capacity of circulating endothelial progenitor cells (EPCs) in vitro. Improved patency was confirmed by Doppler sonography and arteriography. Histological and scanning electron microscopy illustrated enhanced re-endothelialization process. Treatment with atorvastatin enhanced the circulating pool of EPCs with fortified migratory and adherent capacity. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showed that atorvastatin treatment increased endothelial nitric oxide synthase (eNOS) and kinase insert domain receptor (KDR) messenger RNA (mRNA) expression in cultured EPCs and neointima. In conclusion, intensive statin therapy could be considered a favorable option to improve small-diameter vascular graft patency.
Collapse
Affiliation(s)
- Jie Li
- Department of Vascular Surgery, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Paraskevas KI, Tzovaras AA, Stathopoulos V, Gentimi F, Mikhailidis DP. Increased fluorodeoxyglucose uptake following endovascular abdominal aortic aneurysm repair: a predictor of endoleak? Open Cardiovasc Med J 2010; 4:117-9. [PMID: 20657717 PMCID: PMC2908925 DOI: 10.2174/1874192401004010117] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2010] [Revised: 03/09/2010] [Accepted: 03/11/2010] [Indexed: 11/22/2022] Open
Abstract
The main criterion for abdominal aortic aneurysm (AAA) repair is an AAA diameter ≥5.5 cm. However, some AAAs rupture when they are smaller. Size alone may therefore not be a sufficient criterion to determine rupture risk. Fluorodeoxyglucose (FDG) uptake is increased in the presence of inflammation and it was suggested that this may be a better predictor of rupture risk than AAA size. Furthermore, increased FDG uptake following endovascular AAA repair may be an indirect predictor of continuous AAA sac enlargement due to the presence of an endoleak (even if this is not detected by imaging modalities) and/or increased AAA rupture risk. The role of FDG uptake needs to be explored further in the management of AAAs.
Collapse
|
15
|
Paraskevas KI, Tzovaras AA, Gentimi F, Kyriakides ZS, Mikhailidis DP. Predictors of Abdominal Aortic Aneurysm (AAA) Growth and AAA Rupture Risk Besides AAA Size: Fact or Fiction? Angiology 2010; 61:321-3. [DOI: 10.1177/0003319709360526] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
| | | | - Fotini Gentimi
- 2nd Department of Pediatric Surgery, Aghia Sophia Children's Hospital, Athens, Greece
| | | | - Dimitri P. Mikhailidis
- Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK
| |
Collapse
|
16
|
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 2010; 51:242-51. [DOI: 10.1016/j.jvs.2009.08.087] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2009] [Revised: 08/24/2009] [Accepted: 08/26/2009] [Indexed: 11/21/2022]
|
17
|
Paraskevas KI, Andrikopoulou M, Anastasakis E, Perrea D, Mikhailidis DP. Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms: A Possible Pathway for the Effect of Statins? Angiology 2009; 61:226-7; author reply 227-8. [DOI: 10.1177/0003319709353168] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
| | | | | | - Despina Perrea
- Department of Experimental Surgery and Surgical Research "N. S. Christeas", Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Dimitri P. Mikhailidis
- Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, United Kingdom
| |
Collapse
|
18
|
Kölbel T, Donath T, Strandberg K, Flondell-Sité D, Kühme T, Gottsäter A, Lindblad B. Is Increased Thrombin Activation in Patients With Abdominal Aortic Aneurysms Dependent on Area or Volume of Aneurysm Thrombus Mass? Angiology 2009; 61:113-8. [DOI: 10.1177/0003319709335906] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objectives: Does thrombin activation seen in patients with abdominal aortic aneurysms (AAA) relate to the thrombus surface area or volume within the aneurysm? Patients and methods: A total of 130 patients with AAA were analyzed regarding levels of the complex between activated protein C—protein C inhibitor (APC-PCI) and AAA morphology. Analysis of APC-PCI complex was made using a sandwich immunofluorometric method. Results: Increased APC-PCI concentrations were seen in patients with AAA (0.44 μg/L; P < .001 compared with controls). The correlations of APC-PCI values were r = .13, P = .13 for aneurysm size, r = .08, P = .35 for thrombus surface area, and r = .13, P = .14 for thrombus volume. APC-PCI values elevated to 0.45 μg/L in 10 patients with AAA having no or very little thrombus mass. Conclusion: Disappointingly, no correlation was found between thrombus surface area or volume and levels of the APC-PCI complex. Mechanisms other than the AAA-sac thrombus must be evaluated as cause of thrombin activation in patients with AAA.
Collapse
Affiliation(s)
- Tilo Kölbel
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden,
| | - Tobias Donath
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| | - Karin Strandberg
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| | - Despina Flondell-Sité
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| | - Tobias Kühme
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| | - Anders Gottsäter
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| | - Bengt Lindblad
- Departments of Vascular Diseases and Clinical Chemistry, University Hospital MAS, Malmö, Sweden
| |
Collapse
|
19
|
Paraskevas KI. Regarding "Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms". J Vasc Surg 2009; 49:1631; author reply 1631-2. [PMID: 19497529 DOI: 10.1016/j.jvs.2008.08.093] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2008] [Revised: 08/19/2008] [Accepted: 08/19/2008] [Indexed: 10/20/2022]
|
20
|
Paraskevas KI. Regarding "The benefit of statins in non-cardiac vascular surgery patients". J Vasc Surg 2009; 49:1636; author reply 1636. [PMID: 19362443 DOI: 10.1016/j.jvs.2009.02.213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2009] [Revised: 01/28/2009] [Accepted: 02/03/2009] [Indexed: 10/20/2022]
|
21
|
Paraskevas KI. Regarding "Growth predictors and prognosis of small abdominal aortic aneurysms". J Vasc Surg 2008; 48:1067; author reply 1067. [PMID: 18992443 DOI: 10.1016/j.jvs.2008.06.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2008] [Revised: 06/05/2008] [Accepted: 06/06/2008] [Indexed: 10/21/2022]
|
22
|
|
23
|
Badger SA, O'Donnell ME, Sharif MA, Boyd CS, Hannon RJ, Lau LL, Lee B, Soong CV. Risk Factors for Abdominal Aortic Aneurysm and the Influence of Social Deprivation. Angiology 2008; 59:559-66. [DOI: 10.1177/0003319708321586] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Introduction: the objective of this abdominal aortic aneurysm (AAA) screening study was to determine attendance and disease prevalence patterns in Northern Ireland and the role of deprivation and other risk factors. Patients and methods: patients from primary care practices from Belfast, Lisburn, and Saintfield were screened. Past medical history and deprivation details were determined. Results: 2264 men from Belfast, 1104 men in Lisburn, and 284 in Saintfield were invited to attend. Overall, 1659 (45.3%) men attended, with 40.6% from Belfast, 55.0% from Lisburn, and 45.8% from Saintfield ( P < .0001). Ninety-two (5.5%) new AAAs were diagnosed, with 6.5%, 3.8%, and 6.2% in the 3 areas ( P = .055). As deprivation decreased, attendance increased and prevalence decreased. Smoking, peripheral arterial disease, number of medications prescribed, and geographical origin were independent risk factors for AAAs. Conclusion: aneurysm prevalence is influenced by geographical origin and deprivation, which should, therefore, be important factors in health care planning and screening provision.
Collapse
Affiliation(s)
- Stephen A. Badger
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland,
| | - Mark E. O'Donnell
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Muhammed A. Sharif
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Christopher S. Boyd
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Raymond J. Hannon
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Louis L. Lau
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Bernard Lee
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| | - Chee V. Soong
- Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, Northern Ireland
| |
Collapse
|